These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2345838)

  • 1. Factorial and reciprocal control designs.
    Byar DP
    Stat Med; 1990; 9(1-2):55-63; discussion 63-4. PubMed ID: 2345838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Cancer Institute Multi-Screening Trial.
    Prorok P
    Can J Oncol; 1994 Nov; 4 Suppl 1():98-9; discussion 100-1. PubMed ID: 8853500
    [No Abstract]   [Full Text] [Related]  

  • 3. Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Andriole GL
    Recent Results Cancer Res; 2014; 202():53-7. PubMed ID: 24531777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete factorial designs for randomized clinical trials.
    Byar DP; Herzberg AM; Tan WY
    Stat Med; 1993 Sep; 12(17):1629-41. PubMed ID: 8235181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERSPC, PLCO studies and critique of cochrane review 2013.
    Schröder FH
    Recent Results Cancer Res; 2014; 202():59-63. PubMed ID: 24531778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.
    Gohagan JK; Prorok PC; Kramer BS; Cornett JE
    J Urol; 1994 Nov; 152(5 Pt 2):1905-9. PubMed ID: 7523735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Clinical Research Using Factorial Designs: A Primer.
    Baker TB; Smith SS; Bolt DM; Loh WY; Mermelstein R; Fiore MC; Piper ME; Collins LM
    Behav Ther; 2017 Jul; 48(4):567-580. PubMed ID: 28577591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for prostate cancer: opportunities for prevention.
    Thompson IM; Coltman CA
    Semin Urol Oncol; 1996 May; 14(2 Suppl 2):4-10; discussion 10-1. PubMed ID: 8725886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The state of the organized screening in Hungary in 2006].
    Kovács A; Döbrôssy L; Budai A; Cornides A; Boncz I
    Orv Hetil; 2007 Mar; 148(10):435-40. PubMed ID: 17350908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of cancer of the most frequent localizations].
    Belialova NS; Belialov FI
    Klin Med (Mosk); 2005; 83(10):4-9. PubMed ID: 16320836
    [No Abstract]   [Full Text] [Related]  

  • 11. An examination of effect estimation in factorial and standardly-tailored designs.
    Allore HG; Murphy TE
    Clin Trials; 2008; 5(2):121-30. PubMed ID: 18375650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in designing a randomized trial of surveillance colonoscopy in IBD.
    Bernstein CN
    Inflamm Bowel Dis; 1998 May; 4(2):132-41. PubMed ID: 9589298
    [No Abstract]   [Full Text] [Related]  

  • 13. Trying to improve the compliance to colorectal cancer screening: a complex study design for a complex planning question.
    Giorgi Rossi P; Federici A; Bartolozzi F; Farchi S; Borgia P; Guasticchi G
    Contemp Clin Trials; 2005 Jun; 26(3):323-30. PubMed ID: 15911466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factorial designs: an overview with applications to orthodontic clinical trials.
    Pandis N; Walsh T; Polychronopoulou A; Katsaros C; Eliades T
    Eur J Orthod; 2014 Jun; 36(3):314-20. PubMed ID: 23885023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.
    Kramer BS; Gohagan J; Prorok PC; Smart C
    Cancer; 1993 Jan; 71(2 Suppl):589-93. PubMed ID: 8420681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task.
    Marcus PM
    Rev Recent Clin Trials; 2015; 10(3):172. PubMed ID: 26435287
    [No Abstract]   [Full Text] [Related]  

  • 17. Cigarettes: a smoking gun in cancer chemoprevention.
    Mayne ST; Lippman SM
    J Natl Cancer Inst; 2005 Sep; 97(18):1319-21. PubMed ID: 16174848
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for prostate cancer: reflecting on the quality of evidence from the ERSPC and PLCO studies.
    Ilic D
    Recent Results Cancer Res; 2014; 202():65-71. PubMed ID: 24531779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based cancer screening.
    Champion VL; Rawl SM; Menon U
    Oncol Nurs Forum; 2002 Jun; 29(5):853-61. PubMed ID: 12058160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient designs: factorial randomized trials.
    Whelan DB; Dainty K; Chahal J
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():34-8. PubMed ID: 22810445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.